Bibliographic Details
| Title: |
Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registry data in Japan |
| Authors: |
Tetsuya Suzuki, Yusuke Asai, Shinya Tsuzuki, Hidetoshi Nomoto, Nobuaki Matsunaga, Eiichi N. Kodama, Kayoko Hayakawa, Norio Ohmagari |
| Source: |
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 1, Pp 20-29 (2024) |
| Publisher Information: |
Elsevier, 2024. |
| Publication Year: |
2024 |
| Collection: |
LCC:Microbiology |
| Subject Terms: |
Booster vaccination, Coronavirus, Delta variant, Omicron variant, Vaccine effectiveness, Microbiology, QR1-502 |
| More Details: |
Background: To date, few studies from the Asian region have reported the effectiveness of messenger ribonucleic acid coronavirus disease 2019 (COVID-19) vaccines against disease progression and death after hospitalization. Methods: We evaluated the data from the COVID-19 registry in Japan during the delta- and omicron-dominant phases. A propensity score-matched cohort study was conducted between the incompletely (0–1 dose) and fully (2 doses) vaccinated groups during the delta-dominant phase and among the incompletely, fully, and booster (3 doses) vaccinated groups during the omicron-dominant phase. Results: In the delta-dominant phase, 411 pairs were matched. The fully vaccinated group showed a significantly lower oxygen supplementation rate (24.1 % vs. 41.1 %, p |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1684-1182 |
| Relation: |
http://www.sciencedirect.com/science/article/pii/S1684118223002165; https://doaj.org/toc/1684-1182 |
| DOI: |
10.1016/j.jmii.2023.12.002 |
| Access URL: |
https://doaj.org/article/0412faac43d54ce5aafc972df6be0b3b |
| Accession Number: |
edsdoj.0412faac43d54ce5aafc972df6be0b3b |
| Database: |
Directory of Open Access Journals |
